Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine

We have previously described the generation of a novel Ebola virus (EBOV) vaccine platform based on (a) replication-competent rabies virus (RABV), (b) replication-deficient RABV, or (c) chemically inactivated RABV expressing EBOV glycoprotein (GP). Mouse studies demonstrated safety, immunogenicity,...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaney, Joseph E., Marzi, Andrea, Willet, Mallory, Papaneri, Amy B., Wirblich, Christoph, Feldmann, Friederike, Holbrook, Michael, Jahrling, Peter, Feldmann, Heinz, Schnell, Matthias J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667758/
https://www.ncbi.nlm.nih.gov/pubmed/23737747
http://dx.doi.org/10.1371/journal.ppat.1003389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667758/
https://www.ncbi.nlm.nih.gov/pubmed/23737747
http://dx.doi.org/10.1371/journal.ppat.1003389

Ejemplares similares